PTGX Protagonist Therapeutics drops 255 after Q4 2025 EPS misses analyst estimates by a wide 385 margin What Sturm RGR disclosed about cost pressures Q1 2026 Profit Disappoints Why Ross Stores ROST might surprise investors this quarter 140 20260511 VALE SA VALE posts steep Q4 2025 EPS miss despite mild YoY revenue growth shares edge slightly lower Morgan Stanley MS BFH Investment Thesis Evolves Amid Mixed Analyst Targets and Strategic Partnership Wins CEPT Q1 2026 Earnings EPS Surges 96 Above Estimates Amid Investment Gains LAW Q1 2026 Earnings EPS Beat Drives Stock Higher AEE Q1 2026 Earnings EPS Beats Estimates as Utility Gains on Operational Efficiency Peraso Inc PRSO Q1 2026 Earnings Narrower Revenue Disclosure as EPS Misses Estimates CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue Magyar Bancorp MGYR Edges Lower Amid Modest Pullback Key Support Levels Hold Acco Group Holdings ACCL Edges Higher as Stock Approaches Key Resistance Tyra Biosciences TYRA Surges 345 as Biotech Momentum Builds Adagene Inc ADAG Nears Support as Modest Decline Continues KNOT Offshore Partners Q4 2025 Earnings Significant Earnings Miss Highlights Operational Challenges TV Q1 2026 Earnings Stunning EPS Surprise Drives Positive Market Reaction UPXI Q1 2026 Earnings Massive EPS Miss Sends Stock Lower Grindr Inc Q4 2025 Earnings EPS Misses Estimates Despite Positive User Trends ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress GNLX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Hut 8 Corp Q3 2024 Earnings Narrows Loss Expectancy with EPS Beat